Anti-Human IL17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)

SKU: HS856106

Size:100ug

Description:

Host species:Humanized

Tested applications:

Species reactivity:Human

Form:Liquid

Storage buffer:0.01M PBS, pH 7.4.

Purity:>95% as determined by SDS-PAGE.

Clonality:Monoclonal

Isotype:IgG4-kappa-[scFv]2

Applications:ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Target:CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor

Purification:Protein A/G purified from cell culture supernatant.

Endotoxin level:Please contact us for this information.

Expression system:Mammalian Cells

Accession:Q16552 & Q9Y275

Stability and Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Reconstitution:

Background:

Alternative Names:Bispecific, LY 3090106, LY-3090106, LY3090106, 1849636-24-3

Clone ID:

Species:Human

Note:For research use only. Not suitable for clinical or therapeutic use.